Masonic Cancer Center

A comprehensive cancer center designated by the National Cancer Institute

Members in the News

NOTE: News organizations may not keep articles permanently on their sites. As a result, links to news items that have expired may not work.

2016
  • January
    • Carol Lange, Ph.D., Cell Signaling Program leader, is featured in the story on mentoring in the lab - “Back to School” -  in Endocrine News. The story also features Lange’s most recent graduate and a former Cancer Biology Training Grant Predoctoral fellow, Caroline Diep, Ph.D. Read more on page 33.
    • The Masonic Cancer Center is mentioned in a Big Ten Cancer Research Consortium BTN LiveBIG story on cervical cancer, "Working to save lives from cervical cancer."
    • Pamala Jacobson, Pharm.D., Transplant Biology and Therapy Program, is quoted in a Minnesota Daily report on the discovery that an anti-immune drug can prevent the spread of cancer.
    • The Masonic Cancer Center was mentioned in a PRNewswire report on Oxis International, Inc. debt restructuring. The report notes that this will pave the way for moving forward with the Phase 1/Phase 2 FDA clinical trial in collaboration with the Masonic Cancer Center, University of Minnesota.
    • Timothy Church, Ph.D., Screening, Prevention, Etiology and Cancer Survivorship program, will be on the advisory board of a new company that was formed by Illumina to enable early cancer detection via blood-based screening. Read more in Business WireGenetic, Engineering and Biotechnology News, PharmaBiz.
    • Research by Joseph Neglia, M.D., M.P.H., Screening, Prevention, Etiology and Cancer Survivorship program, was featured in Health News Digest. 
    • Business Wire and GEN announced that Illumina has formed a new company, GRAIL, to enable cancer screening from a simple blood test. GRAIL will develop a pan-cancer screening test by directly measuring circulating nucleic acids. Timothy Church, Ph.D.,  Screening, Prevention, Etiology and Cancer Survivorship Program, has been named to the new company’s advisory board.
    • The Masonic Cancer Center was mentioned in a BPLeader.com story about a cancer auction in Faribault that raises funds for the Eagles Cancer Telethon each January.  The telethon raises money for cancer research at Mayo Clinic, Hormel Institute for Cancer Research and the Masonic Cancer Center. This year’s telethon is scheduled for January 16-17.
    • Robert Turesky, Ph.D., Carcinogenesis and Chemoprevention Program, is quoted in a Student Science article about the World Health Organization report on the cancer risk associated with consumption of processed meats.
    • Business Wire and GEN announced that Illumina has formed a new company, GRAIL, to enable cancer screening from a simple blood test. GRAIL will develop a pan-cancer screening test by directly measuring circulating nucleic acids. Timothy Church, Ph.D., Screening, Prevention, Etiology and Cancer Survivorship Program, has been named to the new company’s advisory board.
    • The Masonic Cancer Center was mentioned in a BPLeader.com story about a cancer auction in Faribault that raises funds for the Eagles Cancer Telethon each January. The telethon raises money for cancer research at Mayo Clinic, Hormel Institute for Cancer Research and the Masonic Cancer Center. This year’s telethon is scheduled for January 16-17.
    • Robert Turesky, Ph.D., Carcinogenesis and Chemoprevention Program, is quoted in a Student Science article about the World Health Organization report on the cancer risk associated with consumption of processed meats.
  • February
  • ©2014 Regents of the University of Minnesota. All rights reserved.
  • The University of Minnesota is an equal opportunity educator and employer
  • Last modified on February 1, 2016